A new treatment that has the ability to help lung cancer patients has been approved by NHS Scotland.
The Scottish Medicines Consortium (SMC) has made the decision to allow the drug, named Keytruda or pembrolizumab, to be used along with chemotherapy to treat people at an advanced stage of the most common form of lung cancer. The decision has been welcomed by doctors and campaigners alike.
Scheduled Maintenance We are making some improvements to your service, which will require essential planned maintenance and downtime during the weekend of Saturday 25th and Sunday 26th January 2020. Your service will be offline during the period below: Planned Start: Saturday 25th January, 09:00 BST | Planned End: Sunday 26th January, 18:00 BST The downtime will enable a significant upgrade to your service, paving the way for higher performance levels and new features and functionality.
We will be working to ensure that the downtime experienced will be minimal and apologise for any inconvenience which this may cause.